Morphological Changes of Cortical and Hippocampal Neurons after Treatment with VEGF and Bevacizumab

AIMS: Vascular endothelial growth factor (VEGF) is a hallmark of glioblastoma multiforme (GBM) and plays an important role in brain development and function. Recently, it has been reported that treatment of GBM patients with bevacizumab, an anti‐VEGF antibody, may cause a decline in neurocognitive f...

Descripción completa

Detalles Bibliográficos
Autores principales: Latzer, Pauline, Schlegel, Uwe, Theiss, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067574/
https://www.ncbi.nlm.nih.gov/pubmed/26861512
http://dx.doi.org/10.1111/cns.12516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067574/
https://www.ncbi.nlm.nih.gov/pubmed/26861512
http://dx.doi.org/10.1111/cns.12516

Ejemplares similares